Conifa
Pharmaceutical - Medical Nutrition
Conifa
Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.
Conifa is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Available in: Each 5 mg film coated tablet contains: Solifenacin succinate 5mg equivalent to Solifenacin 3.8mg Each 10 mg film coated tablet contains: Solifenacin succinate 10mg equivalent to Solifenacin 7.5mg